Risperidone on apomorphine-induced stereotyped behavior and auditory sensory gating in rhesus monkeys

被引:1
作者
Iwamura, Yoshihiro [1 ]
Nakako, Tomokazu [1 ]
Matsumoto, Atsushi [1 ]
Ogi, Yuji [1 ]
Yamaguchi, Masataka [1 ]
Kobayashi, Atsushi [1 ]
Matsumoto, Kenji [1 ]
Katsura, Yasunori [1 ]
Ikeda, Kazuhito [1 ]
机构
[1] Sumitomo Pharma Co Ltd, Drug Res Div, Platform Technol Res Unit, Osaka, Japan
关键词
Non-human primate; Rhesus monkey; Stereotyped behavior; Auditory sensory gating; Apomorphine; Risperidone; RECEPTOR AGONIST XANOMELINE; ANTIPSYCHOTIC-LIKE ACTIVITY; PREPULSE INHIBITION; PARKINSONS-DISEASE; DOPAMINE-RECEPTORS; P50; SUPPRESSION; SCHIZOPHRENIA; BINDING; AMPHETAMINE; RATS;
D O I
10.1016/j.bbr.2022.113883
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The ameliorating effect of risperidone on apomorphine-induced stereotyped behavior and inhibition of auditory sensory gating was investigated using rhesus monkeys. The total duration of the stereotyped behavior observed in the control group was 43.7 +/- 23.0 s (n = 3) between 10 and 25 min after vehicle administration, whereas the duration in the apomorphine-treated (0.1 or 0.15 mg/kg i.m., n = 3) group was observed to be significantly prolonged to 413.0 +/- 150.6 s. Administration of 0.01, 0.03, 0.1 mg/kg of risperidone 60 min before apomorphine, significantly reduced the duration of this apomorphine-induced stereotyped behavior to 327 +/- 104.9 s (n = 3), 8.3 +/- 4.2 s (n = 3), and 0.0 +/- x 0.0 s (n = 3, t-test: p < 0.05), respectively. Next, the auditory sensory gating test/conditioning (T/C) ratio was used as a bio-marker. The T/C ratio was 0.598 +/- 0.0802 in the vehicle-administered control group (n = 4) and was significantly increased to 2.098 +/- 0.254 (n = 4) by apomorphine (0.15 mg/kg, i.m.). Administering of risperidone (0.1 mg/kg, s.c.) 30 min before apomorphine treatment significantly restricted the T/C ratio to 0.571 +/- 0.0886 (n = 4), compared to the T/C ratio in the vehicle-administered control group. The above results demonstrate, not only behaviorally but also electrophysiologically, the ameliorating effect of risperidone on the induction of schizophrenia-like symptoms by apomorphine in non-human primates.
引用
收藏
页数:7
相关论文
共 46 条
  • [1] Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
    Abi-Dargham, A
    Rodenhiser, J
    Printz, D
    Zea-Ponce, Y
    Gil, R
    Kegeles, LS
    Weiss, R
    Cooper, TB
    Mann, JJ
    Van Heertum, RL
    Gorman, JM
    Laruelle, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) : 8104 - 8109
  • [2] NEUROPHYSIOLOGICAL STUDIES OF SENSORY GATING IN RATS - EFFECTS OF AMPHETAMINE, PHENCYCLIDINE, AND HALOPERIDOL
    ADLER, LE
    ROSE, G
    FREEDMAN, R
    [J]. BIOLOGICAL PSYCHIATRY, 1986, 21 (8-9) : 787 - 798
  • [3] The muscarinic M1/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys
    Andersen, MB
    Fink-Jensen, A
    Peacock, L
    Gerlach, J
    Bymaster, F
    Lundbæk, JA
    Werge, T
    [J]. NEUROPSYCHOPHARMACOLOGY, 2003, 28 (06) : 1168 - 1175
  • [4] The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future
    Auffret, Manon
    Drapier, Sophie
    Verin, Marc
    [J]. DRUGS IN R&D, 2018, 18 (02) : 91 - 107
  • [5] Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients
    Boutros, Nash N.
    Brockhaus-Dumke, Anke
    Gjini, Klevest
    Vedeniapin, Andrei
    Elfakhani, Mohamad
    Burroughs, Scott
    Keshavan, Matcheri
    [J]. SCHIZOPHRENIA RESEARCH, 2009, 113 (2-3) : 339 - 346
  • [6] Meta-analysis of the P300 and P50 waveforms in schizophrenia
    Bramon, E
    Rabe-Hesketh, S
    Sham, P
    Murray, RM
    Frangou, S
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 70 (2-3) : 315 - 329
  • [7] Sensory Gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients
    Brockhaus-Dumke, Anke
    Schultze-Lutter, Frauke
    Mueller, Ralf
    Tendolkar, Indira
    Bechdolf, Andreas
    Pukrop, Ralf
    Klosterkoetter, Joachim
    Ruhrmann, Stephan
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 64 (05) : 376 - 384
  • [8] Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?
    Chaudhuri, K. Ray
    Rizos, Alexandra
    Sethi, Kapil D.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (09) : 1305 - 1320
  • [9] Colpaert F C, 1976, Int Rev Neurobiol, V19, P225, DOI 10.1016/S0074-7742(08)60705-9
  • [10] CLIMBING BEHAVIOR INDUCED BY APOMORPHINE IN MICE - POTENTIAL MODEL FOR DETECTION OF NEUROLEPTIC ACTIVITY
    COSTALL, B
    NAYLOR, RJ
    NOHRIA, V
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 50 (01) : 39 - 50